| Bioactivity | NCRW0005-F05 is a potent GPR139 antagonist with an IC50 value of 0.21 μM. NCRW0005-F05 can be used to research diabetes, obesity and Parkinson's disease[1]. | |||||||||
| Target | IC50: 0.21 μM (GPR139) | |||||||||
| Name | NCRW0005-F05 | |||||||||
| CAS | 342779-66-2 | |||||||||
| Formula | C16H13F2NO2 | |||||||||
| Molar Mass | 289.28 | |||||||||
| Appearance | Solid | |||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | |||||||||
| Storage |
|
|||||||||
| Reference | [1]. Wang J, et al. High-throughput screening of antagonists for the orphan G-protein coupled receptor GPR139. Acta Pharmacol Sin. 2015 Jul;36(7):874-8. |
NCRW0005-F05
CAS: 342779-66-2 F: C16H13F2NO2 W: 289.28
NCRW0005-F05 is a potent GPR139 antagonist with an IC50 value of 0.21 μM. NCRW0005-F05 can be used to research diabetes
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.